Does contrast media volume affect long-term survival in patients with chronic kidney disease?

Ismail Biyik1, Fatih Uzun2, Mehmet Erturk2

  • 1Department of Cardiology, Usak University, School of Medicine, Usak, Turkey.

Insights

This study found that older age, higher contrast media volume, and lower estimated glomerular filtration rate (e-GFR) predict mortality in chronic kidney disease patients undergoing cardiac procedures. Lower use of angiotensin II receptor blockers (ARBs) also increased mortality risk.

Area of Science:

  • Nephrology
  • Cardiology
  • Medical Imaging

Background:

  • Patients with chronic kidney disease (CKD) are at increased risk during cardiac procedures.
  • Cardiac catheterization and coronary angiography are common diagnostic procedures for cardiovascular conditions.
  • Understanding survival predictors in CKD patients undergoing these procedures is crucial for risk stratification and management.

Purpose of the Study:

  • To investigate the relationship between survival and various clinical features in CKD patients undergoing cardiac catheterization and coronary angiography.
  • To identify independent predictors of long-term all-cause mortality in this high-risk population.

Main Methods:

  • A cohort of 307 consecutive patients with an estimated glomerular filtration rate (e-GFR) < 60 ml/min/1.73 m2 undergoing coronary angiography was studied.
  • Patients were followed for a median duration of 41.5 months.
  • Cox proportional hazards regression models were used to identify independent predictors of mortality.

Main Results:

  • Independent predictors of long-term all-cause mortality included older age (HR=1.047), higher contrast media volume (HR=1.004), lower e-GFR (HR=0.978), and lower angiotensin II receptor blocker (ARB) use (HR=0.485).
  • Patients receiving > 140 ml of contrast media had a significantly higher mortality rate (11.6%) compared to those receiving ≤ 140 ml (3.6%) (log-rank p=0.001).
  • The p-value for e-GFR was 0.04, indicating it was a significant predictor.

Conclusions:

  • Age, contrast media volume, e-GFR, and low ARB use are independent predictors of long-term mortality in CKD patients undergoing cardiac catheterization.
  • Using more than 140 ml of contrast media during cardiac catheterization is independently associated with increased long-term all-cause mortality.
  • These findings highlight the importance of minimizing contrast media exposure and optimizing medical therapy in CKD patients undergoing angiography.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
354
Imaging Studies VII: Vascular Imaging01:19

Imaging Studies VII: Vascular Imaging

DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
391
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
235
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
492
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
502
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
993